Intas Pharmaceuticals
-
Intas Pharmaceuticals in licensing agreement with mAbxience
The agreement accelerates Intas’ global mission to enable innovative and affordable treatment options for autoimmune diseases Intas Pharmaceuticals announced a…
Read More » -
Intas launches DCGI-approved Tofacitinib Ointment to treat atopic dermatitis
Patients who desire a steroid-free topical agent for Atopic Dermatitis will be benefitted Intas Pharmaceuticals, one of India’s leading pharmaceutical…
Read More » -
Intas Pharma, Comera Life Sciences in research collaboration
Comera will develop a differentiated formulation of an Intas product using Comera’s innovative proprietary SQore formulation platform Intas Pharmaceuticals announced…
Read More » -
Intas Pharma launches SB-100mg Itraconazole
The medical breakthrough will significantly reduce cost and increase compliance in patients undergoing antifungal therapy Intas Pharmaceuticals has made a…
Read More » -
Intas Pharma launches Azadine-O
The leukaemia drug will bridge a long-pending unmet need in cancer therapy Ahmedabad-based Intas Pharmaceuticals has launched oral azacitidine in…
Read More » -
Intas in exclusive licensing agreement with Meiji and Dong-A ST
Intas has been granted exclusive license rights to commercialise DMB-3115 worldwide, excluding Japan, Korea and certain countries in Asia Intas…
Read More »